Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dutka

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
European Heart Journal|September 1, 1995
Plasma neuro-endocrine activity in very elderly subjects and patients with and without heart failureD P Dutka, I Olivotto, S Ward, et al.
Angiology|December 25, 2008
Remote ischemic preconditioning stimulus does not reduce microvascular resistance or improve myocardial blood flow in patients undergoing elective percutaneous coronary interventionStephen P Hoole, Patrick M Heck, Paul A White, et al.
The Journal of Laryngology and Otology|March 20, 2010
Heart rate and blood pressure effects during caloric vestibular testingAnand V Kasbekar, D M Baguley, R Knight, et al.
Circulation. Cardiovascular Interventions|May 19, 2011
A pilot study to assess whether glucagon-like peptide-1 protects the heart from ischemic dysfunction and attenuates stunning after coronary balloon occlusion in humansPhilip A Read, Stephen P Hoole, Paul A White, et al.
Cardiovascular Diabetology|August 9, 2015
Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitusLiam M McCormick, Patrick M Heck, Liam S Ring, et al.
Heart (British Cardiac Society)|March 4, 2000
Prolonged left ventricular dysfunction occurs in patients with coronary artery disease after both dobutamine and exercise induced myocardial ischaemiaE Barnes, C S Baker, D P Dutka, et al.
Circulation. Cardiovascular Interventions|May 23, 2013
Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-upWilliam R Davies, Adam J Brown, William Watson, et al.
Circulation. Cardiovascular Imaging|February 8, 2014
Chronic dipeptidyl peptidase-4 inhibition with sitagliptin is associated with sustained protection against ischemic left ventricular dysfunction in a pilot study of patients with type 2 diabetes mellitus and coronary artery diseaseLiam M McCormick, Anna C Kydd, Philip A Read, et al.
Pacing and Clinical Electrophysiology : PACE|July 30, 2011
Cardiac resynchronization therapy optimization using noninvasive cardiac output measurementFakhar Z Khan, Munmohan S Virdee, John Hutchinson, et al.
JACC. Cardiovascular Interventions|April 20, 2010
Stunning and cumulative left ventricular dysfunction occurs late after coronary balloon occlusion in humans insights from simultaneous coronary and left ventricular hemodynamic assessmentStephen P Hoole, Patrick M Heck, Paul A White, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
European Heart Journal|September 1, 1995
Plasma neuro-endocrine activity in very elderly subjects and patients with and without heart failureD P Dutka, I Olivotto, S Ward, et al.
Angiology|December 25, 2008
Remote ischemic preconditioning stimulus does not reduce microvascular resistance or improve myocardial blood flow in patients undergoing elective percutaneous coronary interventionStephen P Hoole, Patrick M Heck, Paul A White, et al.
The Journal of Laryngology and Otology|March 20, 2010
Heart rate and blood pressure effects during caloric vestibular testingAnand V Kasbekar, D M Baguley, R Knight, et al.
Circulation. Cardiovascular Interventions|May 19, 2011
A pilot study to assess whether glucagon-like peptide-1 protects the heart from ischemic dysfunction and attenuates stunning after coronary balloon occlusion in humansPhilip A Read, Stephen P Hoole, Paul A White, et al.
Cardiovascular Diabetology|August 9, 2015
Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitusLiam M McCormick, Patrick M Heck, Liam S Ring, et al.
Heart (British Cardiac Society)|March 4, 2000
Prolonged left ventricular dysfunction occurs in patients with coronary artery disease after both dobutamine and exercise induced myocardial ischaemiaE Barnes, C S Baker, D P Dutka, et al.
Circulation. Cardiovascular Interventions|May 23, 2013
Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-upWilliam R Davies, Adam J Brown, William Watson, et al.
Circulation. Cardiovascular Imaging|February 8, 2014
Chronic dipeptidyl peptidase-4 inhibition with sitagliptin is associated with sustained protection against ischemic left ventricular dysfunction in a pilot study of patients with type 2 diabetes mellitus and coronary artery diseaseLiam M McCormick, Anna C Kydd, Philip A Read, et al.
Pacing and Clinical Electrophysiology : PACE|July 30, 2011
Cardiac resynchronization therapy optimization using noninvasive cardiac output measurementFakhar Z Khan, Munmohan S Virdee, John Hutchinson, et al.
JACC. Cardiovascular Interventions|April 20, 2010
Stunning and cumulative left ventricular dysfunction occurs late after coronary balloon occlusion in humans insights from simultaneous coronary and left ventricular hemodynamic assessmentStephen P Hoole, Patrick M Heck, Paul A White, et al.
Pageof 8